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ABSTRACT
Objective: Previous studies indicate an increased
short-term and long-term mortality from major cancer
surgery performed towards the end of the working
week or during the weekend. We hypothesised that the
prognosis after major cancer surgery is also negatively
influenced by surgery conducted during holiday
periods.
Setting: Population-based nationwide Swedish cohort
study.
Participants: Patients undergoing oesophagectomy
for oesophageal cancer between 1987 and 2010.
Among 1820 included patients, 206 (11.3%) and 373
(20.5%) patients were operated on during narrow and
wide holiday periods, respectively.
Interventions: Narrow (7 weeks) and wide (14 weeks)
Swedish holiday periods.
Primary and secondary outcome measures: 90-
day all-cause, 5-year all-cause and 5-year disease-
specific mortality.
Results: Narrow holiday period did not increase all-
cause 90-day (HR=0.84, 95% CI 0.53 to 1.33), all-
cause 5-year (HR=1.01, 95% CI 0.85 to 1.21) or
disease-specific 5-year mortality (HR=1.04, 95% CI
0.87 to 1.26). Similarly, wide holiday period did not
increase the risk of 90-day (HR=0.79, 95% CI 0.55 to
1.13), all-cause 5-year (HR=0.96, 95% CI 0.84 to 1.1)
or disease-specific 5-year mortality (HR=1.03, 95% CI
0.89 to 1.19).
Conclusions: No measurable effects of holiday
periods on short-term or longer term mortality
following surgery for oesophageal cancer were
observed in this population-based study, indicating that
an adequate surgical experience was maintained during
holiday periods.
INTRODUCTION
Large studies from the UK and US of various
elective surgical procedures have shown
increased 30-day mortality if the procedures
were carried out on Friday or a weekend.1 2
These results may be attributable to lower
stafﬁng density and experience during week-
ends, and have led to a call for a 7-day
working week in the UK healthcare. Other
studies have suggested that short-term and
long-term mortality from major cancer
surgery is inﬂuenced by both the hospital
and surgeon volume,3–6 and the resources
available to the centre to rescue the patient
following a major complication.7 In a recent
study, we found an intriguing increased long-
term mortality with each later weekday of
oesophageal cancer surgery during the week-
days Monday to Friday, particularly for earlier
tumour stages.8 In the present study, we
hypothesised that surgical timing with
respect to calendar period may also inﬂu-
ence the prognosis following major cancer
surgery. During holiday periods the experi-
ence and density of the surgeons and staff
may be lower, which may contribute to worse
outcomes. Oesophagectomy for cancer
represents the ideal procedure to test this
hypothesis, as it is a high-risk elective surgical
procedure with a signiﬁcant rate of measure-
able short-term and long-term mortality and
has a stronger association with the experi-
ence of the hospital and surgeon than most
other procedures.4 Sweden was considered
Strengths and limitations of this study
▪ The population-based design with virtually com-
plete inclusion of all eligible patients in Sweden.
▪ The large sample size, complete follow-up of all
patients and the adjustment for all relevant con-
founding factors are other advantages.
▪ The Swedish system with personal identity
numbers of all residents and a nationwide popu-
lation registry for dates and causes of death
enabled complete assessment of mortality,
without loss to follow-up.
▪ Retrospective observational in design.
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an ideal country for this study because of its distinct
holiday periods. We tested the new hypothesis that
major cancer surgery conducted during holiday periods
is followed by worse prognosis in a nationwide Swedish
study of oesophageal cancer surgery.
METHODS
Study design
The design of this population-based cohort study has been
described in detail elsewhere.9 In brief, this Swedish
nationwide cohort study included 98% of all patients with
oesophageal cancer treated with curative intended surgery
between 1987 and 2010 with follow-up until November
2014. From the Swedish Cancer Registry, patients with a
diagnosis of oesophageal cancer (150.0, 150.8 or 150.9)
were identiﬁed according to the seventh edition of the
International Classiﬁcation of Diseases (ICD7). This
Cancer Registry has 98% nationwide coverage of oesopha-
geal cancer.10 11 Patients with oesophageal cancer who
underwent oesophagectomy were identiﬁed from the
Swedish Patient Registry, which has an excellent positive
identiﬁcation rate (99.6%) for oesophageal cancer
surgery.12 The Patient Registry also provided data pertain-
ing to patient medical comorbidities.12 The comorbidities
were classiﬁed according to the well-validated Charlson
comorbidity index, and we did not count the oesophageal
cancer diagnosis.13 The Swedish Causes of Death Registry
provided accurate data for date and causes of death. This
Registry has 100% coverage. If the diagnosis oesophageal
cancer was listed as a cause of death, this mortality was
deﬁned as disease speciﬁc. The Swedish personal identity
number, assigned to each Swedish resident at birth or
immigration, was used to link individuals’ data between
registries and to identify their medical records. The clin-
ical data collection was facilitated by a nationwide Swedish
clinical network established in the mid-1990s.14 Medical
records containing operation notes and histopathology
reports of the cohort members were retrieved from all
Swedish hospitals where oesophageal cancer surgery was
performed during the study period. Data concerning
neoadjuvant therapy, surgical therapy, names of the sur-
geons, pathological tumour stage and histological type
were obtained from these individual patient records. The
histopathological review has been demonstrated for its
high accuracy.15 Neoadjuvant therapy was predominantly
used in more recent years and when used was typically a
combination of chemotherapy and radiotherapy. Tumour
stage was classiﬁed according to the tumour nodal metasta-
sis (TNM) classiﬁcation of the Union Internationale
Contre le Cancer (UICC).16 Open transthoracic oesopha-
geal resection with intrathoracic anastomosis was the dom-
inating surgical procedure (95%). The Regional Ethical
Review Board in Stockholm, Sweden approved the study.
Exposures, outcomes and covariates
The exposures tested were a 7-week ‘narrow holiday
period’ (25 June to 15 August) and a 14-week ‘wide
holiday period’ (16 December to 7 January and 16 June
to 31 August). The outcomes were all-cause 90-day and
5-year mortality as well as disease-speciﬁc 5-year mortal-
ity. Covariates considered as potential confounding
factors were age (continuous variable), pathological
TNM stage (0, I, II, III or IV), Charlson Comorbidity
Index (0, I or ≥I), neoadjuvant therapy (yes or no),
histological type (adenocarcinoma or squamous cell car-
cinoma) and cumulative surgeon volume of oesophagec-
tomies during study period (≤6, 7 to 16 or 17 to 46).
Statistical analysis
Kaplan–Meier survival analysis was conducted to visualise
crude long-term all-cause and disease-speciﬁc mortality.
The holiday periods were analysed in relation to mortality
using a multivariable Cox-proportional hazards model,
providing HRs with 95% CIs, adjusted for the seven poten-
tial confounding factors with categorisations as described
above. These factors were included in the multivariable
model because of their known prognostic inﬂuence. To
manage missing data (0.8%), a complete case analysis was
carried out. The patients who underwent surgery during
the narrow holiday period were compared with patients
outside the narrow holiday period and with those outside
the wide holiday period. Since the study period was long,
we added a stratiﬁed analysis for an earlier calendar
period (1987–1999) and a later calendar period (2000–
2010). Follow-up ended at the date of death or end of
study period, whichever occurred ﬁrst. The statistical soft-
ware SPSS V.22.0 (Statistical Package for the Social
Sciences software, V.22, SPSS Chicago, Illinois, USA) was
used for the data management and statistical analysis.
RESULTS
Patients
During the study period from 1987 to 2010, 1820
patients who underwent surgery for oesophageal cancer
were included. Characteristics of these patients are pre-
sented in table 1. The average age was 65.1 years, with
the majority of patients (58.5%) having a Charlson
comorbidity index of 0. The incidences of 90-day all-
cause, 5-year all-cause and 5-year disease-speciﬁc mortal-
ity were 11.4%, 74.7% and 79.7%, respectively. In total,
206 (11.3%) and 373 (20.5%) patients were operated on
during narrow and wide holiday periods, respectively.
Comparison of patient demographics of operated on
inside and outside of holiday periods, showed no major
differences, except for an increased proportion of
patients with Charlson comorbidity index >1 within the
holiday periods (table 1).
Narrow holiday period and mortality
Kaplan–Meier survival analysis showed that oesophagect-
omy during the narrow holiday period did not affect all-
cause 90-day (p=0.84), all-cause 5-year (p=0.97) (ﬁgure 1)
or disease-speciﬁc 5-year mortality (p=0.79). Regression
analysis with adjustment for potential confounders further
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showed that narrow holiday period did not increase the
risk of all-cause 90-day (HR=0.84, 95% CI 0.53 to 1.33), all-
cause 5-year (HR=1.01, 95% CI 0.85 to 1.21) or disease-
speciﬁc 5-year mortality (HR=1.04, 95% CI 0.87 to 1.26)
(table 2). Stratiﬁed analysis for earlier and later calendar
periods showed no association between surgery during
narrow holiday period and the risk of all-cause 90-day, all-
cause 5-year or disease-speciﬁc 5-year mortality (data not
shown).
Wide holiday period and mortality
Kaplan–Meier survival analysis showed that oesophagect-
omy during wide holiday periods did not affect all-cause
90-day (p=0.43), all-cause 5-year (p=0.77) (ﬁgure 2) or
disease-speciﬁc 5-year mortality (p=0.90). Regression
analysis with adjustment for relevant confounders
further showed no increased risk of all-cause 90-day
(HR=0.79, 95% CI 0.55 to 1.13), all-cause 5-year
(HR=0.96, 95% CI 0.84 to 1.1) or disease-speciﬁc 5-year
mortality (HR=1.03, 95% CI 0.89 to 1.19) (table 2). The
analysis stratiﬁed for calendar periods showed no associ-
ation between surgery during wide holiday period and
the risk of all-cause 90-day, all-cause 5-year and disease-
speciﬁc 5-year mortality (data not shown).
DISCUSSION
The results of this study disprove the hypothesis that
oesophageal cancer surgery conducted during holiday
periods increases the risk of short-term or long-term
mortality.
The population-based design with virtually complete
inclusion of all eligible patients in Sweden is a major
Table 1 Characteristics of study patients undergoing surgery for oesophageal cancer in Sweden in 1987–2010
Narrow holiday period
number (%)
Wide holiday periods
number (%)
Variable Total number (%) No (%) (n=1447) Yes (%) (n=206) No (%) (n=1447) Yes (%) (n=373)
Mean age (SD) 65.1 (9.6) 65.1 (9.7) 64.9 (9.0) 65.1 (9.7) 65.2 (9.1)
Charlson comorbidity index
0 1064 (58.5) 863 (59.6) 108 (52.4) 863 (59.6) 201 (53.9)
1 375 (20.6) 301 (20.8) 45 (21.8) 301 (20.8) 74 (19.8)
>1 381 (20.9) 283 (19.6) 53 (25.7) 283 (19.6) 98 (26.3)
Tumour stage
0–I 422 (23.4) 339 (23.6) 52 (25.4) 339 (23.6) 83 (22.3)
II 662 (36.7) 523 (36.5) 76 (37.1) 523 (36.5) 139 (37.4)
III–IV 722 (40.0) 572 (39.9) 77 (37.6) 572 (39.9) 150 (40.3)
Tumour histology
Adenocarcinoma 792 (43.6) 639 (44.3) 83 (40.5) 639 (44.3) 153(41.1)
Squamous cell carcinoma 1024 (56.4) 805 (55.7) 122 (59.5) 805 (55.7) 219 (58.9)
Neoadjuvant therapy
No 1231 (67.7) 986 (68.2) 131 (63.6) 986 (68.2) 245 (65.7)
Yes 587 (32.3) 459 (31.8) 75 (36.4) 459 (31.8) 128 (34.3)
Cumulative surgeon volume
≤6 1108 (63.0) 880 (62.8) 127 (64.8) 880 (62.8) 228 (63.5)
7–16 569 (32.3) 455 (32.5) 60 (30.6) 455 (32.5) 114 (31.8)
17–46 83 (4.7) 66 (4.7) 9 (4.6) 66 (4.7) 17 (4.7)
Calendar period
1987–1999 992 (54.5) 790 (54.6) 112 (54.4) 790 (54.6) 202 (54.2)
2000–2010 828 (45.5) 657 (45.4) 94 (45.6) 657 (45.4) 171 (45.8)
Patients who underwent surgery during the narrow holiday period were compared with patients outside the narrow holiday period and with
those outside the wide holiday period.
Figure 1 Kaplan–Meier survival curve for the effect of
surgery of oesophageal cancer during a narrow holiday period
(7 weeks) on all-cause 5-year survival.
Markar SR, et al. BMJ Open 2016;6:e013069. doi:10.1136/bmjopen-2016-013069 3
Open Access
strength of the study. The large sample size, complete
follow-up of all patients and the adjustment for all relevant
confounding factors are other advantages. There are also
limitations associated with retrospective observational
studies such as this. However, the cohort used for this study
has high accuracy in the correct identiﬁcation of patients
undergoing oesophagectomy for cancer, and the clinical
data were collected from extensive review of medical
records, which made it possible to have accurate and
detailed information on exposures and covariates, not the
least on key variables like date of surgery, surgeons’ names
and tumour stage. Finally, the Swedish system with personal
identity numbers of all residents and a nationwide popula-
tion registry for dates and causes of death enabled com-
plete assessment of mortality, without loss to follow-up.
The present study shows that during narrow and wider
holiday periods when stafﬁng levels are potentially less
experienced and somewhat depleted, there is no effect
on postoperative short-term or long-term mortality. In
view of the strong association between surgeon volume
of oesophagectomies and mortality,4–6 these results
reassuringly indicate that the experience of the surgeons
is well maintained during holiday periods, at least in
Sweden. This might be due to good planning of proce-
dures to when the experienced surgeons are available
during holiday periods and to well working referral
systems of patients to other hospitals where the required
expertise is available even during holiday periods.
To the best of our knowledge, this is the ﬁrst study to
examine the effect of cancer surgery during holiday
periods on mortality. Thus, more research is needed
and one should be cautious when considering any
administrative or structural recommendations based on
the ﬁndings of this single study. It would be of interest
to consider an alternative population where the pres-
ence of surgical experience during the holiday period
might be lower or in a centralised cancer service such as
the UK, to further investigate this hypothesis. In a
modern era with a low rate of perioperative mortality
further studies may also include assessment of more
subtle outcomes from oesophagectomy including com-
plications, length of hospital stay and hospital transfer.
The negative results of the present study might be gen-
eralisable to other cancer surgical procedures. In the
absence of any effect of surgery during holiday periods
for oesophageal cancer on mortality, it seems unlikely
that any such effect would exist for cancer procedures
where the inﬂuence of surgeon volume is absent or
weaker.
In conclusion, this large national study has demon-
strated no worse mortality following major cancer
surgery, in this study exempliﬁed by oesophageal cancer
surgery, during holiday periods. The beneﬁt of ensuring
a strategy for maintaining an adequate surgical experi-
ence even during holiday periods is recommended.
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